308 related articles for article (PubMed ID: 22292765)
1. Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.
Shen M; Chan TH; Dou QP
Anticancer Agents Med Chem; 2012 Oct; 12(8):891-901. PubMed ID: 22292765
[TBL] [Abstract][Full Text] [Related]
2. Polyphenols counteract tumor cell chemoresistance conferred by multidrug resistance proteins.
Michalak K; Wesolowska O
Anticancer Agents Med Chem; 2012 Oct; 12(8):880-90. PubMed ID: 22583399
[TBL] [Abstract][Full Text] [Related]
3. Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials.
Nabavi SF; Atanasov AG; Khan H; Barreca D; Trombetta D; Testai L; Sureda A; Tejada S; Vacca RA; Pittalà V; Gulei D; Berindan-Neagoe I; Shirooie S; Nabavi SM
Cancer Lett; 2018 Oct; 434():101-113. PubMed ID: 30030139
[TBL] [Abstract][Full Text] [Related]
4. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.
Narayanan S; Cai CY; Assaraf YG; Guo HQ; Cui Q; Wei L; Huang JJ; Ashby CR; Chen ZS
Drug Resist Updat; 2020 Jan; 48():100663. PubMed ID: 31785545
[TBL] [Abstract][Full Text] [Related]
5. Targeting multiple myeloma with natural polyphenols.
Pojero F; Poma P; Spanò V; Montalbano A; Barraja P; Notarbartolo M
Eur J Med Chem; 2019 Oct; 180():465-485. PubMed ID: 31330448
[TBL] [Abstract][Full Text] [Related]
6. Natural polyphenols properties: chemopreventive and chemosensitizing activities.
Delmas D; Xiao J
Anticancer Agents Med Chem; 2012 Oct; 12(8):835. PubMed ID: 22583400
[No Abstract] [Full Text] [Related]
7. Apigenin, chrysin, and luteolin selectively inhibit chymotrypsin-like and trypsin-like proteasome catalytic activities in tumor cells.
Wu YX; Fang X
Planta Med; 2010 Feb; 76(2):128-32. PubMed ID: 19653143
[TBL] [Abstract][Full Text] [Related]
8. Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy.
Frezza M; Schmitt S; Dou QP
Curr Top Med Chem; 2011 Dec; 11(23):2888-905. PubMed ID: 21824109
[TBL] [Abstract][Full Text] [Related]
9. The proteasome as a potential target for novel anticancer drugs and chemosensitizers.
Landis-Piwowar KR; Milacic V; Chen D; Yang H; Zhao Y; Chan TH; Yan B; Dou QP
Drug Resist Updat; 2006 Dec; 9(6):263-73. PubMed ID: 17197231
[TBL] [Abstract][Full Text] [Related]
10. Search for Inhibitors of the Ubiquitin-Proteasome System from Natural Sources for Cancer Therapy.
Tsukamoto S
Chem Pharm Bull (Tokyo); 2016; 64(2):112-8. PubMed ID: 26833439
[TBL] [Abstract][Full Text] [Related]
11. Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.
Soave CL; Guerin T; Liu J; Dou QP
Cancer Metastasis Rev; 2017 Dec; 36(4):717-736. PubMed ID: 29047025
[TBL] [Abstract][Full Text] [Related]
12. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
Li H; Krstin S; Wink M
Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
[TBL] [Abstract][Full Text] [Related]
13. Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
Golonko A; Pienkowski T; Swislocka R; Lazny R; Roszko M; Lewandowski W
Eur J Med Chem; 2019 Apr; 167():291-311. PubMed ID: 30776692
[TBL] [Abstract][Full Text] [Related]
14. The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells.
Yerlikaya A; Kanbur E
Curr Drug Targets; 2020; 21(13):1313-1325. PubMed ID: 32448101
[TBL] [Abstract][Full Text] [Related]
15. Effects of Hydroxy Groups in the A-Ring on the Anti-proteasome Activity of Flavone.
Nakamura K; Yang JH; Sato E; Miura N; Wu YX
Biol Pharm Bull; 2015; 38(6):935-40. PubMed ID: 25810454
[TBL] [Abstract][Full Text] [Related]
16. Recent Patents on Proteasome Inhibitors of Natural Origin.
da Silva DC; Andrade PB; Ribeiro V; Valentao P; Pereira DM
Recent Pat Anticancer Drug Discov; 2017; 12(1):4-15. PubMed ID: 27881056
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.
Wang S; Chen R; Zhong Z; Shi Z; Chen M; Wang Y
Am J Chin Med; 2014; 42(5):1279-300. PubMed ID: 25242081
[TBL] [Abstract][Full Text] [Related]
18. Bio-active Natural Products with TRAIL-Resistance Overcoming Activity.
Ahmed F; Ishibashi M
Chem Pharm Bull (Tokyo); 2016; 64(2):119-27. PubMed ID: 26833440
[TBL] [Abstract][Full Text] [Related]
19. Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy.
Driscoll JJ; Dechowdhury R
Target Oncol; 2010 Dec; 5(4):281-9. PubMed ID: 21125340
[TBL] [Abstract][Full Text] [Related]
20. Targeting the ubiquitin+proteasome system in solid tumors.
Driscoll JJ; Woodle ES
Semin Hematol; 2012 Jul; 49(3):277-83. PubMed ID: 22726552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
